Skip to main content
. 2020 Jun 18;12(6):1819. doi: 10.3390/nu12061819

Figure 3.

Figure 3

Effects of AP-NHm on dyslipidemias: intracellular triglyceride concentration in co-treatment (a) and post-injury (b) regimens; total cholesterol concentration in co-treatment (c) and post-injury (d) regimens. HepG2 were incubated with 0.5-mM oleic acid in 1% BSA (OA/BSA) or BSA alone for 24 h in co-treatment or in post-injury recovery treatment (48 h) with AP-NHm 1, 2, 3. ** p < 0.01 vs. BSA + vehicle, ^ p < 0.05 and ^^ p < 0.01 vs. OA/BSA + vehicle.